| Literature DB >> 26448872 |
Lara Pasovic1, Jon Roger Eidet2, Berit S Brusletto2, Torstein Lyberg2, Tor P Utheim3.
Abstract
Purpose. Replacement of the diseased retinal pigment epithelium (RPE) with cells capable of performing the specialized functions of the RPE is the aim of cell replacement therapy for treatment of macular degenerative diseases. A storage method for RPE is likely to become a prerequisite for the establishment of such treatment. Herein, we analyze the effect of storage temperature on key functions of cultured RPE cells. Methods. Cultured ARPE-19 cells were stored in Minimum Essential Medium at 4°C, 16°C, and 37°C for seven days. Total RNA was isolated and the gene expression profile was determined using DNA microarrays. Comparison of the microarray expression values with qRT-PCR analysis of selected genes validated the results. Results. Expression levels of several key genes involved in phagocytosis, pigment synthesis, the visual cycle, adherens, and tight junctions, and glucose and ion transport were maintained close to control levels in cultures stored at 4°C and 16°C. Cultures stored at 37°C displayed regulational changes in a larger subset of genes related to phagocytosis, adherens, and tight junctions. Conclusion. RPE cultures stored at 4°C and 16°C for one week are capable of maintaining the expression levels of genes important for key RPE functions close to control levels.Entities:
Year: 2015 PMID: 26448872 PMCID: PMC4584032 DOI: 10.1155/2015/263756
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Expression of genes involved in key functions of the RPE at different temperatures compared to controls.
| Gene symbol | Gene description | Fold change | ||
|---|---|---|---|---|
| 4°C versus C | 16°C versus C | 37°C versus C | ||
| Phagocytosis | ||||
| ANXA2 | Annexin A2 | −1.07 | −1.06 | −1.21 |
| ARPC2 | Actin related protein 2/3 complex, subunit 2, 34 kDa | −1.04 | −1.01 |
|
| CD81 | CD81 molecule | −1.04 | 1.01 | −1.10 |
| CTSD | Cathepsin D | 1.11 | 1.05 |
|
| GAS6 | Growth arrest-specific 6 | −1.03 | −1.01 | −1.09 |
| ITGAV | Integrin, alpha V | 1.02 | −1.05 | −1.05 |
| ITGB2 | Integrin, beta 2 | 1.06 | 1.03 | 1.06 |
| ITGB5 | Integrin, beta 5 | 1.01 | −1.01 | 1.01 |
| LAMP2 | Lysosomal-associated membrane protein 2 | 1.03 | −1.00 |
|
| MerTK | MER protooncogene, tyrosine kinase | 1.04 | 1.00 | 1.73 |
| MFGE8 | Milk fat globule-EGF factor 8 protein | 1.07 | −1.01 | 1.32 |
| MYO7A | Myosin VIIa | 1.31 | 1.02 | 1.28 |
| PROS1 | Protein S | 1.06 | 1.02 |
|
| PTDSS1 | Phosphatidylserine synthase 1 |
| 1.11 |
|
| TLR4 | Toll-like receptor 4 | −1.07 | −1.08 | −1.15 |
| WASP | Wiskott-Aldrich syndrome | 1.06 | 1.10 |
|
|
| ||||
| Pigment synthesis | ||||
| GPR143 | G protein-coupled receptor 143 | 1.05 | 1.14 | 1.33 |
| MITF | Microphthalmia-associated transcription factor | 1.12 |
| 1.03 |
| OCA2 | Oculocutaneous albinism II | 1.03 | 1.05 | 1.03 |
| PMEL | Premelanosome protein | 1.12 | 1.03 | −1.02 |
| SLC45A2 | Solute carrier family 45, member 2 | 1.18 |
| 1.28 |
| TYRP1 | Tyrosinase-related protein 1 | 1.03 | 1.02 |
|
|
| ||||
| Visual cycle | ||||
| CRABP1 | Cellular retinoic acid binding protein 1 | 1.08 |
| 1.11 |
| CRABP2 | Cellular retinoic acid binding protein 2 | −1.03 |
|
|
| LRAT | Lecithin retinol acyltransferase | −1.01 | −1.21 | −1.23 |
| RBP1 | Retinol binding protein 1, cellular | −1.09 | −1.00 | 1.15 |
| RBP3 | Retinol binding protein 3, interstitial | 1.05 | 1.06 | 1.03 |
| RBP5 | Retinol binding protein 5, cellular | 1.13 | 1.03 | 1.14 |
| RBP7 | Retinol binding protein 7, cellular | 1.01 | 1.04 |
|
| RDH11 | Retinol dehydrogenase 11 |
| 1.00 | 1.06 |
| RDH14 | Retinol dehydrogenase 14 | 1.03 |
|
|
| RLBP1 | Retinaldehyde binding protein 1 | −1.00 | 1.21 |
|
|
| ||||
| Adherens junctions | ||||
| CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | 1.11 | 1.22 | 1.21 |
| CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | −1.02 | −1.07 | −1.23 |
| CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | −1.02 | 1.07 | −1.35 |
| CDH6 | Cadherin 6, type 2, K-cadherin (fetal kidney) | 1.12 | −1.12 |
|
| CDH10 | Cadherin 10, type 2 (T2-cadherin) | 1.06 | −1.27 |
|
| CDH11 | Cadherin 11, type 2, OB-cadherin (osteoblast) | −1.08 | −1.43 |
|
| CDH13 | Cadherin 13 | −1.05 | 1.03 |
|
| CDH15 | Cadherin 15 | 1.08 | 1.12 | 1.05 |
| CDH16 | Cadherin 16, KSP-cadherin | 1.08 | 1.09 | 1.07 |
| CDH17 | Cadherin 17, LI cadherin (liver-intestine) | 1.14 | −1.02 | 1.35 |
| CDH22 | Cadherin 22, type 2 | 1.06 | 1.02 | 1.04 |
| CDH23 | Cadherin-related 23 | 1.09 |
| 1.08 |
| CDH24 | Cadherin 24, type 2 | 1.01 | 1.01 | 1.13 |
| DSC1 | Desmocollin 1 | 1.11 | 1.08 |
|
| DSC2 | Desmocollin 2 | 1.06 | 1.01 | 1.11 |
| DSC3 | Desmocollin 3 | 1.09 | −1.04 |
|
|
| ||||
| Tight junctions | ||||
| ACTB | Actin, beta | −1.05 | −1.02 |
|
| CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | −1.04 |
|
|
| CLDN3 | Claudin 3 | 1.14 | −1.01 |
|
| CLDN9 | Claudin 9 | −1.02 | 1.08 |
|
| CLDN11 | Claudin 11 | −1.11 | 1.07 |
|
| CLDN15 | Claudin 15 | 1.04 | −1.07 |
|
| CLDN18 | Claudin 18 | 1.12 |
| 1.12 |
| CLDN19 | Claudin 19 | 1.13 | 1.12 | 1.15 |
| CLDN23 | Claudin 23 | 1.13 |
| 1.14 |
| CRB3 | Crumbs family member 3 |
|
|
|
| CTNNA | Catenin (cadherin-associated protein), alpha 1 | −1.03 | −1.03 | 1.03 |
| F11R | F11 receptor | −1.02 | 1.04 |
|
| JAM3 | Junctional adhesion molecule 3 | −1.08 | 1.01 |
|
| MAGI1 | Membrane associated guanylate kinase, WW and PDZ domain containing 1 | 1.03 |
| −1.08 |
| MAGI3 | Membrane associated guanylate kinase, WW and PDZ domain containing 3 | −1.04 |
|
|
| MPDZ | Multiple PDZ domain protein | 1.09 |
| 1.01 |
| MYO7A | Myosin VIIA | 1.31 | 1.02 | 1.28 |
| OCLN | Occludin | 1.09 | −1.15 | 1.49 |
| PTEN | Phosphatase and tensin homolog | 1.02 | −1.01 |
|
| RAB3B | RAB3B, member RAS oncogene family | −1.15 | 1.08 |
|
| TJP1 | Tight junction protein 1 | 1.02 | −1.10 | −1.02 |
| TJP2 | Tight junction protein 2 | −1.01 | 1.25 |
|
| TJP3 | Tight junction protein 3 | 1.06 | 1.08 | 1.04 |
|
| ||||
| Glucose transport | ||||
| SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | 1.04 | −1.01 | 1.05 |
| SLC2A3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | 1.11 |
| 1.13 |
| SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | 1.05 | 1.12 | 1.05 |
| SLC2A5 | Solute carrier family 2 (facilitated glucose transporter), member 5 | 1.10 | 1.16 | 1.13 |
| SLC2A6 | Solute carrier family 2 (facilitated glucose transporter), member 6 | −1.11 | 1.03 | −1.06 |
| SLC2A8 | Solute carrier family 2 (facilitated glucose transporter), member 8 | 1.01 |
|
|
| SLC2A10 | Solute carrier family 2 (facilitated glucose transporter), member 10 | 1.07 | 1.13 | 1.14 |
| SLC2A11 | Solute carrier family 2 (facilitated glucose transporter), member 11 | 1.08 | −1.01 | 1.07 |
| SLC2A12 | Solute carrier family 2 (facilitated glucose transporter), member 12 | −1.08 | −1.39 |
|
| SLC2A13 | Solute carrier family 2 (facilitated glucose transporter), member 13 | 1.01 | −1.05 | −1.08 |
| SLC2A14 | Solute carrier family 2 (facilitated glucose transporter), member 14 | 1.08 |
| 1.07 |
|
| ||||
| Na-K-ATPase | ||||
| ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | −1.04 | −1.03 |
|
| ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 1.08 | 1.06 | 1.22 |
| ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | −1.01 |
| 1.17 |
| ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | 1.01 | 1.12 | −1.01 |
| ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | 1.10 |
| 1.09 |
| ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide | −1.16 | 1.10 |
|
P values < 0.05 are marked in bold font.
Figure 1Heat map diagrams of a selection of the most important genes related to RPE phagocytosis, pigment synthesis, adherens junctions, and visual cycle, respectively. The color scale illustrates the relative expression level of mRNAs: green color represents a high expression level and orange color represents a low expression level.
Figure 2Heat map diagrams of a selection of the most important genes related to RPE tight junctions, glucose transportation, and Na-K-ATPase, respectively. The color scale illustrates the relative expression level of mRNAs: green color represents a high expression level and orange color represents a low expression level.
Figure 3Validation of microarray expression results by qRT-PCR. Selected mRNAs (TYRP1, DSC1, and GLUT12) were differentially expressed in cultured RPE cells stored at different temperatures (4°C, 16°C, or 37°C) compared to control cells that had not been stored. Black bars indicate microarray expression values and grey bars represent PCR verification values. P < 0.01.